Medical management for cerebellar mutism syndrome following posterior fossa surgery: A systematic review

Clin Neurol Neurosurg. 2024 Jul:242:108352. doi: 10.1016/j.clineuro.2024.108352. Epub 2024 May 23.

Abstract

Introduction: Cerebellar mutism syndrome (CMS) is a serious complication of posterior fossa surgeries affecting mainly pediatric age group. The pathophysiology is still not fully understood. It adversely affects the recovery of patients. There is no definitive and standardized management for CMS. However pharmacological therapy has been used in reported cases with variable effectiveness. We aim through this review to summarize the available evidence on pharmacological agents used to treat CMS.

Method: A thorough systematic review until December 2022, was conducted using PubMed Central, Embase, and Web of Science, databases to identify case reports and case series of CMS patients who underwent posterior fossa surgery and received pharmacological treatment. Patients with pathologies other than posterior fossa lesions were excluded from the study.

Results: Of 592 initial studies, 8 studies met our eligibility criteria for inclusion, with 3 more studies were added through manual search; reporting on 13 patients. The median age of 13 years (Standard deviation SD=10.60). The most frequent agent used was Bromocriptine. Other agents were fluoxetine, midazolam, zolpidem, and arpiprazole. Most patients recovered within 48 hours of initiating medical therapy. The median follow-up period was 4 months (SD=13.8). All patients showed complete recovery at the end of follow-up period.

Conclusion: Cerebellar mutism syndrome is reported after posterior fossa surgeries, despite attempts to identify risk factors, pathophysiology, and management of CMS, it remains a challenging condition with significant morbidity. Different Pharmacological treatments have been proposed with promising results. Further studies and formalized clinical trials are needed to evaluate available options and their effectiveness.

Keywords: Akinetic mutism; Cerebellum; Medulloblastoma; Mutism; Posterior Fossa Syndrome.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Adolescent
  • Cerebellar Diseases / etiology
  • Cerebellar Diseases / surgery
  • Child
  • Cranial Fossa, Posterior / surgery
  • Humans
  • Mutism* / etiology
  • Neurosurgical Procedures* / adverse effects
  • Postoperative Complications* / drug therapy
  • Postoperative Complications* / etiology
  • Postoperative Complications* / therapy